Artificial Intelligence | Machine Learning | Natural Language Processing Ablacon | AI-guided Atrial Fibrillation Therapies.

Consumer, Heart, Therapeutics, Healthcare, Medical Records, Analytics, Patient Support Greater Denver Area, Western US, CO, United States

Ablacon

Artificial Intelligence | Machine Learning | Natural Language Processing

Ablacon | AI-guided Atrial Fibrillation Therapies.

Ablacon

Heart, Therapeutics, Healthcare, Medical Records, Analytics, Patient Support

Greater Denver Area, Western US, CO, United States

Ablacon - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - World's Most Promising AI Startups & AI Ecosystem of 10,000+ AI Startups appengine.ai Get Started

Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system.

We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE).

 
 

   Total Funding: $33.5M

   Funding Stage: Series B

   Business Stage: Development

   Market: B2G, B2B

   Company Size: 26 to 50

   Founded: 2015

 
 
 
 
Duke Rohlen


Duke Rohlen
CEO

Josef Koblish

Josef Koblish
Chief Strategy Officer

Peter Ruppersberg


Peter Ruppersberg
Chief Scientific Officer & President

Melissa Kong


Melissa Kong
Associate Medical Director

Ablacon Ablacon - Manage Profile
 
 

Ablacon is growing. Want to work at Ablacon? Ablacon is hiring. Join team at Ablacon

 
 
appengine.ai

World's Most Promising AI Startups


Pony.ai
Observe.AI
Kodiak Robotics
OpenAI
Abnormal Security
Groq
Cohere
Anthropic



World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals


Get Started